Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial
暂无分享,去创建一个
I. Thompson | P. Goodman | C. Tangen | S. Lippman | Yue Wu | E. Platz | S. Yao | M. Neuhouser | J. Reichardt | C. Ambrosone | W. Figg | R. Santella | A. Hsing | Li Tang | F. Stanczyk | M. Platek | C. Till | I. Thompson
[1] V. Pagliarulo. Androgen Deprivation Therapy for Prostate Cancer. , 2018, Advances in experimental medicine and biology.
[2] I. Thompson,et al. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial , 2015, Cancer Causes & Control.
[3] I. Thompson,et al. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial , 2015, The Prostate.
[4] K. Izumi,et al. Active estrogen synthesis and its function in prostate cancer-derived stromal cells. , 2015, Anticancer research.
[5] F. Dudbridge. Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS genetics.
[6] J. Stanford,et al. Association of variants in estrogen‐related pathway genes with prostate cancer risk , 2013, The Prostate.
[7] I. Thompson,et al. Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[8] I. Thompson,et al. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. , 2011, Carcinogenesis.
[9] N. Rifai,et al. The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III) , 2011, Clinical endocrinology.
[10] I. Thompson,et al. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study , 2011, Cancer Causes & Control.
[11] A. Meikle. Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in Men , 2010 .
[12] I. Thompson,et al. Single and Multigenic Analysis of the Association between Variants in 12 Steroid Hormone Metabolism Genes and Risk of Prostate Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.
[13] I. Thompson,et al. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. , 2008, American journal of epidemiology.
[14] I. Thompson,et al. CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians , 2008, Carcinogenesis.
[15] A. Roddam,et al. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. , 2008, Journal of the National Cancer Institute.
[16] F. Hamdy,et al. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Cummings,et al. Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women , 2007, Breast Cancer Research and Treatment.
[18] J. Long,et al. Genetic Polymorphisms of the CYP19A1 Gene and Breast Cancer Survival , 2006, Cancer Epidemiology Biomarkers & Prevention.
[19] R. Dellinger,et al. IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10) IN THE DETOXIFICATION OF POLYCYCLIC AROMATIC HYDROCARBONS: DECREASED GLUCURONIDATIVE ACTIVITY OF THE UGT1A10139LYS ISOFORM , 2006, Drug Metabolism and Disposition.
[20] H. Grönberg,et al. Estrogen Receptor β Polymorphism Is Associated with Prostate Cancer Risk , 2006, Clinical Cancer Research.
[21] E. Giovannucci,et al. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[22] P. Härkönen,et al. Role of estrogens in development of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[23] Mohamed Helal,et al. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. , 2004, The Journal of urology.
[24] J. F. Schmitt,et al. Local aromatase expression in human prostate is altered in malignancy. , 2004, The Journal of clinical endocrinology and metabolism.
[25] A. Tchernof,et al. Amino acid residue ILE211 is essential for the enzymatic activity of human UDP-glucuronosyltransferase 1A10 (UGT1A10). , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[26] N. Stone,et al. Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions , 2004, Urological Research.
[27] W. Han,et al. Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk. , 2003, Anticancer Research.
[28] D. Cramer,et al. Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. , 2003, American journal of obstetrics and gynecology.
[29] Jianfeng Xu,et al. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk , 2003, International journal of cancer.
[30] X. Shu,et al. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] Michael M Lieber,et al. The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.
[32] J. J. Bianco,et al. Oestrogens and prostate cancer. , 2003, Endocrine-related cancer.
[33] E. Baulieu. Androgens and aging men , 2002, Molecular and Cellular Endocrinology.
[34] J. Miners,et al. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. , 2002, Toxicology.
[35] David Handelsman,et al. Direct response of the murine prostate gland and seminal vesicles to estradiol. , 2002, Endocrinology.
[36] J. Kaufman,et al. Estradiol in elderly men , 2002, The aging male : the official journal of the International Society for the Study of the Aging Male.
[37] A. Børresen-Dale,et al. Genetic susceptibility and environmental estrogen-like compounds. , 2001, Mutation research.
[38] Hong Wang,et al. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. , 2001, Endocrinology.
[39] J. Miners,et al. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. , 2000, Pharmacogenetics.
[40] J. Chang-Claude,et al. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. , 2000, Cancer research.
[41] R. Millikan,et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. , 2000, Cancer research.
[42] T. Key,et al. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies , 1999, British Journal of Cancer.
[43] N. Roodi,et al. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. , 1998, Cancer research.
[44] J. Freudenheim,et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. , 1998, Cancer research.
[45] Fernand Labrie,et al. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology , 1997, Steroids.
[46] J. Simard,et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. , 1997, Steroids.
[47] J. Freudenheim,et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. , 1995, Cancer research.
[48] M. Bosland,et al. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. , 1995, Carcinogenesis.
[49] R. Nass,et al. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. , 1993, The Journal of clinical endocrinology and metabolism.
[50] N. Stone,et al. Estrogen formation in human prostatic tissue from patients with and without benign prostatic hyperplasia , 1986, The Prostate.